4.7 Article

Magnetic Bead Handling Using a Paper-Based Device for Quantitative Point-of-Care Testing

Journal

BIOSENSORS-BASEL
Volume 12, Issue 9, Pages -

Publisher

MDPI
DOI: 10.3390/bios12090680

Keywords

immuno-modified magnetic beads; paper-based diagnostic device; low-cost assay automation; smartphone colorimetric detection; point-of-care testing; malaria quantitative diagnosis

Funding

  1. Fondo de Investigaciones Sanitarias of Instituto de Salud Carlos III (European Regional Development Fund) [CPII18/00025, IFI18/00020, JR18/00022, AC21_2/00021]
  2. La Caixa Foundation [100010434, LCF/BQ/DI18/11660061]
  3. Secretaria d'Universitats i Recerca, Generalitat de Catalunya [2017 SGR 240]

Ask authors/readers for more resources

This article proposes a microfluidic paper-based analytical device (μPAD) produced using a craft-cutter and stored at room temperature, which is used for partially automated single-step colorimetric magneto-immunoassay. With a simple setup and affordable materials, this μPAD achieves quantitative detection of Plasmodium falciparum lactate dehydrogenase (Pf-LDH) in a shorter time and with higher sensitivity compared to commercial rapid diagnostic tests. The results demonstrate the potential of this μPAD in point-of-care testing.
Microfluidic paper-based analytical devices (mu PADs) have been extensively proposed as ideal tools for point-of-care (POC) testing with minimal user training and technical requirements. However, most p.PADs use dried bioreagents, which complicate production, reduce device reproducibility and stability, and require transport and storage under temperature and humidity-controlled conditions. In this work, we propose a mu PAD produced using an affordable craft-cutter and stored at room temperature, which is used to partially automate a single-step colorimetric magneto-immunoassay. As a proof-of-concept, the mu PAD has been applied to the quantitative detection of Plasmodium falciparum lactate dehydrogenase (Pf-LDH), a biomarker of malaria infection. In this system, detection is based on a single-step magneto-immunoassay that consists of a single 5-min incubation of the lysed blood sample with immuno-modified magnetic beads (MB), detection antibody, and an enzymatic signal amplifier (Poly-HRP). This mixture is then transferred to a single-piece paper device where, after on-chip MB magnetic concentration and washing, signal generation is achieved by adding a chromogenic enzyme substrate. The colorimetric readout is achieved by the naked eye or using a smartphone camera and free software for image analysis. This mu PAD afforded quantitative Pf-LDH detection in <15 min, with a detection limit of 6.25 ng mL(-1) when the result was interpreted by the naked eye and 1.4 ng mL(-1) when analysed using the smartphone imaging system. Moreover, the study of a battery of clinical samples revealed concentrations of Pf-LDH that correlated with those provided by the reference ELISA and with better sensitivity than a commercial rapid diagnostic test (RDT). These results demonstrate that magneto-immunoassays can be partly automated by employing a mu PAD, achieving a level of handling that approaches the requirements of POC testing.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available